drugset / Trial / NCT00715013
Patupilone (EPO 906) in Patients With Recurrent or Progressive Glioblastoma
Non-randomizedSingle-groupOpen-labelTreatment
Summary
Patupilone trial for patients with recurrent glioblastoma, which are planned for re-operation. Objectives: prolongation of PFS compared to patients with re-operation only, Patupilone tumor concentrations, pharmacokinetic, Perfusion in MRI pre - and post Patupilone. Translational research of tumor tissue exposed to patupilone. * Trial with medicinal product
Timeline
- Start
- 2008-07
- Primary completion
- 2010-12
- Completion
- 2010-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Patupilone | Small molecule | — | — |